Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 50, Issue 8, Pages 2842-2844Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00250-06
Keywords
-
Categories
Funding
- NIAID NIH HHS [AI35257, AI063431, R21 AI063431, R01 AI035257] Funding Source: Medline
Ask authors/readers for more resources
The C-8-methoxy fluoroquinolone moxifloxacin was more lethal against chloramphenicol-treated Mycobacterium tuberculosis than Bay y3114, a C-8-H cognate of moxifloxacin, and two C-8-methoxy fluoroquinolones, gatifloxacin and BMS-433368, which have different C-7 substituents. Thus, an optimal combination of C-7 and C-8 substituents is likely to be important for killing nongrowing M. tuberculosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available